AMENDMENT AND EXCHANGE AGREEMENTAmendment and Exchange Agreement • May 5th, 2022 • Evofem Biosciences, Inc. • Pharmaceutical preparations
This Amendment and Exchange Agreement (the “Agreement”) is entered into as of the date set forth on the signature pages below, by and among Evofem Biosciences, Inc., a Delaware corporation with offices located at 12400 High Bluff Drive, Suite 600, San Diego, California 92130 (the “Company”) and the investor signatory hereto (the “Holder”), with reference to the following facts:
AMENDMENT AND EXCHANGE AGREEMENTAmendment and Exchange Agreement • May 5th, 2022 • Evofem Biosciences, Inc. • Pharmaceutical preparations
This Amendment and Exchange Agreement (the “Agreement”) is entered into as of the date set forth on the signature pages below, by and among Evofem Biosciences, Inc., a Delaware corporation with offices located at 12400 High Bluff Drive, Suite 600, San Diego, California 92130 (the “Company”) and the investor signatory hereto (the “Holder”), with reference to the following facts:
AMENDMENT AND EXCHANGE AGREEMENTAmendment and Exchange Agreement • May 5th, 2022 • Evofem Biosciences, Inc. • Pharmaceutical preparations
This Amendment and Exchange Agreement (the “Agreement”) is entered into as of the date set forth on the signature pages below, by and among Evofem Biosciences, Inc., a Delaware corporation with offices located at 12400 High Bluff Drive, Suite 600, San Diego, California 92130 (the “Company”) and the investor signatory hereto (the “Holder”), with reference to the following facts:
